Jae Young Seong,Jong Ik Hwang,Woong Sun,Eun Bee Cho,Won-Ki Kim
申请号：
US15404011
公开号：
US10640557B2
申请日:
2017.01.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.
